Skip to main content
Multiple Sclerosis Discovery Forum
User Top Menu
Who We Are
How to Cite
News & Future Directions
Essays & Opinions
Meetings & Events
Clinical Trials - Public Availability of Results
MS trials baseline
Map of MS Prevalence
Progressive MS Authors Galaxy
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Scientific Literature TreeMap
Clinical Trials in MS
Click Here to Support MSDF
You are here
Most Viewed Papers
Safety study of BIIB033 in subjects with multiple sclerosis
A regenerative approach to the treatment of multiple sclerosis.
MRI in multiple sclerosis: what's inside the toolbox?
Autoimmunity's next top models.
MS Drugs in Development: Firategrast, Ocrelizumab, and Ofatumumab
Surrogate endpoints for EDSS worsening in multiple sclerosis. A meta-analytic approach.
Combined MRI lesions and relapses as a surrogate for disability in multiple sclerosis.
Mouse models for multiple sclerosis: historical facts and future implications.
Non-invasive neuromodulation to improve gait in chronic multiple sclerosis: a randomized double blind controlled pilot trial.
Risk alleles for multiple sclerosis identified by a genomewide study.
Studies on the natural history of multiple sclerosis. 3. Epidemiologic analysis of the army experience in World War II.
CXCL12-induced monocyte-endothelial interactions promote lymphocyte transmigration across an in vitro blood-brain barrier.
Magnetic resonance disease severity scale (MRDSS) for patients with multiple sclerosis: A longitudinal study.
LINGO-1 negatively regulates myelination by oligodendrocytes.
Specific aspects of modern life for people with multiple sclerosis: considerations for the practitioner.
The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART'MUS) trial: rationale, objectives and state of advancement.
Histologie de la sclerose en plaques
Depletion of B cells by a humanized anti-CD20 antibody PRO70769 in Macaca fascicularis.
Gray matter imaging in multiple sclerosis: what have we learned?
Experimental autoimmune encephalomyelitis in the mouse.
B-cell depletion with rituximab in relapsing-remitting multiple sclerosis.
Diagnostic criteria for multiple sclerosis: 2010 revisions to the McDonald criteria.
Disability as an outcome in MS clinical trials.
Prevention of experimental autoimmune encephalomyelitis by antibodies against alpha 4 beta 1 integrin.
Myelin oligodendrocyte glycoprotein-specific T and B cells cooperate to induce a Devic-like disease in mice.